PCV38- A COST AND COST-EFFECTIVENESS (CE) ANALYSIS OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORTRANDOLAPRIL IN THE TREATMENT OF POST INFARCTION IN THE US
May 1, 2003, 00:00
10.1016/S1098-3015(10)64152-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)64152-6/fulltext
Title :
PCV38- A COST AND COST-EFFECTIVENESS (CE) ANALYSIS OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORTRANDOLAPRIL IN THE TREATMENT OF POST INFARCTION IN THE US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64152-6&doi=10.1016/S1098-3015(10)64152-6
First page :
Section Title :
Open access? :
No
Section Order :
351